Facebook
Twitter
Telegram
Fehler meldenViking Therapeutics Bilanz 2011-2024 | VKTX
Bilanz Jährlich Viking Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-54.3 M | -35.1 M | - | -28.8 M | -7.72 M | -24.8 M | -5.54 M | 194 K | 14.7 M | 813 K | 99.1 K | 42.8 K | - |
Langfristige Schulden |
936 K | 1.26 M | - | - | - | - | - | - | 2.15 M | 1.26 M | 232 K | 42.8 K | - |
Langfristiger Schuldenstrom |
324 K | 304 K | 29 K | 330 K | 302 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
936 K | 1.26 M | - | - | 360 K | 12 K | - | 16.3 K | 4.74 M | 2.65 M | 304 K | 51 K | - |
Kurzfristige Verbindlichkeiten |
19.1 M | 21.9 M | 8.78 M | 12.1 M | 6.78 M | 4.55 M | 8.66 M | 6.48 M | 1.98 M | - | - | - | - |
Gesamtverbindlichkeiten |
20.1 M | 23.2 M | 8.78 M | 29 K | 7.14 M | 4.56 M | 8.66 M | 6.49 M | 6.71 M | 25.2 M | 431 K | 105 K | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-378 M | -292 M | -223 M | - | -129 M | -103 M | -80.9 M | -60.3 M | -45.5 M | -22.1 M | -257 K | -111 K | - |
Vermögenswerte |
368 M | 169 M | 211 M | 257 M | 284 M | 302 M | 22.1 M | 14.5 M | 15.4 M | 3.04 M | 180 K | - | - |
Zahlungsmittel |
55.5 M | 36.6 M | 26.4 M | 29.1 M | 8.38 M | 24.8 M | 8.99 M | 3.08 M | 769 K | 756 K | - | - | - |
Buchwert |
348 M | 145 M | 202 M | 256 M | 277 M | 298 M | 13.5 M | 8.04 M | 8.72 M | -22.1 M | -251 K | -105 K | - |
Gesamtes Eigenkapital |
348 M | 145 M | 202 M | 244 M | 277 M | 298 M | 13.5 M | 8.04 M | 8.72 M | -22.1 M | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Viking Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
1.02 M | 1.1 M | 1.18 M | 1.26 M | 1.34 M | - | 1.49 M | - | - | - | - | 29 K | 29 K | 29 K | 29 K | 360 K | 360 K | 360 K | 360 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
1.02 M | 1.1 M | 1.18 M | 1.26 M | 1.34 M | - | 1.49 M | - | - | - | - | 29 K | 29 K | 29 K | 29 K | 360 K | 360 K | 360 K | 360 K | 12 K | 12 K | 12 K | 12 K | - | - | 6.05 K | 4.22 M | 16.3 K | 16.3 K | 16.3 K | 16.3 K | 4.74 M | 4.74 M | 4.74 M | 4.74 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
14.4 M | 14.6 M | 16.8 M | 23.2 M | 15.4 M | - | 12.8 M | 8.78 M | 11.4 M | 12.9 M | 12.9 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 7.14 M | 7.14 M | 7.14 M | 7.14 M | 4.56 M | 4.56 M | 4.56 M | 4.56 M | 8.66 M | 8.66 M | 8.66 M | 8.66 M | 6.49 M | 6.49 M | 6.49 M | 6.49 M | 6.71 M | 6.71 M | 6.71 M | 6.71 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-353 M | -331 M | -312 M | -292 M | -272 M | - | -239 M | -223 M | -211 M | -198 M | -182 M | -168 M | -168 M | -168 M | -168 M | -129 M | -129 M | -129 M | -129 M | -103 M | -103 M | -103 M | -103 M | -80.9 M | -80.9 M | -80.9 M | -80.9 M | -60.3 M | -60.3 M | -60.3 M | -60.3 M | -45.5 M | -45.5 M | -45.5 M | -45.5 M | -22.1 M | -22.1 M | -22.1 M | -22.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
383 M | 401 M | 151 M | 169 M | 167 M | - | 195 M | 211 M | 224 M | 238 M | 250 M | 257 M | 257 M | 257 M | 257 M | 284 M | 284 M | 284 M | 284 M | 302 M | 302 M | 302 M | 302 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 3.04 M | 3.04 M | 3.04 M | 3.04 M | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
37.2 M | 69.5 M | 18.4 M | 36.6 M | 29.4 M | - | 12.5 M | 26.4 M | 11.3 M | 8.83 M | 16.8 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 8.38 M | 8.38 M | 8.38 M | 8.38 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 8.99 M | 8.99 M | 8.99 M | 8.99 M | 3.08 M | 3.08 M | 3.08 M | 3.08 M | 769 K | 769 K | 769 K | 769 K | 756 K | 756 K | 756 K | 756 K | 180 K | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
368 M | 386 M | 134 M | 145 M | 151 M | - | 182 M | 202 M | 213 M | 225 M | 237 M | 244 M | 244 M | 244 M | 244 M | 277 M | 277 M | 277 M | 277 M | 298 M | 298 M | 298 M | 298 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 8.04 M | 8.04 M | 8.04 M | 8.04 M | 8.72 M | 8.72 M | 8.72 M | 8.72 M | -22.1 M | -22.1 M | -22.1 M | -22.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
368 M | 386 M | 134 M | 145 M | 151 M | 165 M | 182 M | 202 M | 213 M | 225 M | 237 M | 244 M | 244 M | 244 M | 244 M | 277 M | 277 M | 277 M | 277 M | 298 M | 298 M | 298 M | 298 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 8.04 M | 8.04 M | 8.04 M | 8.04 M | 8.72 M | 8.72 M | 8.72 M | 8.72 M | -22.1 M | -22.1 M | -22.1 M | -22.1 M | -251 K | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung